Rheumatoid arthritis

Patterns of comorbidities differentially affect long-term functional evolution and disease activity in patients with ‘difficult to treat’ rheumatoid arthritis

RMD OpenPublished Prospective cohort study

Authors' conclusion

D2T patients represent a heterogeneous group in terms of long-term disease course. Mental-health/pain-related illnesses as well as metabolic diseases contribute to long-term adverse outcomes

Study context

Population
Patients with RA from a prospective single-centre cohort; Difficult to treat (D2T) defined by the EULAR definition251 D2T
Participants
1,264 patients
Outcome
Long-term evolution of functional status (mHAQ) and disease activity (DAS28) in D2T RA, and contributing factors
Methodological detailssingle-centre, latent-class trajectory analysis, linear mixed models
  • Single-centre
  • Latent-class trajectory analysis
  • Linear mixed models

Main finding

As reported in the abstract

Identified as D2T
251 out of 1264 patients (19.9%)
Functional status (modified Health Assessment Questionnaire (mHAQ)) trajectories: four groups
4
Stable, mildly compromised mHAQ (mean 0.41)
18.2%
Gradual mHAQ improvement (1.21-0.87)
39.9%
Disease activity trajectories: four distinct groups
4
'Mental-health and pain-related illnesses' cluster, contribution to mHAQ worsening
p<0.0001
'Metabolic diseases' cluster, contribution to mHAQ worsening
p<0.0001
'Mental-health and pain-related illnesses' cluster, contribution to DAS28 evolution
p<0.0001
'Metabolic diseases' cluster, contribution to DAS28 evolution
p=0.018

Observational data: associations, not effects.

Further findings

Predictors of becoming D2T

Younger age, FM, OA, DAS28-ESR at first b/tsDMARD initiation and failure to reduce DAS28-ESR within the first 6 months of b/tsDMARD therapy were significant predictors

Original publication

Patterns of comorbidities differentially affect long-term functional evolution and disease activity in patients with ‘difficult to treat’ rheumatoid arthritis. RMD Open. Published 19 January 2024. doi:10.1136/rmdopen-2023-003808

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.